sorafenib has been researched along with HIV Infections in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Aleixo, MJ; Fonseca, C; Fonseca, J; Nunes, G; Patita, M; Ramalho, M | 1 |
| Beasley, JM; Brinster, NK; Lederhandler, M; Nagler, AR | 1 |
| Bai, F; Belli, LS; Mancuso, A; Puoti, M; Zavaglia, C | 1 |
| Delgado-Fernández, M; Galindo, MJ; García, MA; Garcia-Deltoro, M; Ibarra, S; Merchante, N; Merino, E; Mínguez, C; Montero-Alonso, M; Pineda, JA; Revollo, B; Rivero-Juárez, A; Rodríguez-Arrondo, F; Romero-Palacios, A; Téllez, F | 1 |
| Abou-Alfa, GK; Dika, IE; Harding, JJ | 1 |
| Aitini, E; Cengarle, R; Costa, P; Fibbia, GC; Morandini, B; Perboni, G; Scalzini, A; Tagliani, A | 1 |
| Chamalidou, E; Chelis, L; Deftereos, S; Kakolyris, S; Maltezos, E; Ntinos, N; Souftas, V; Xenidis, N | 1 |
| Ciampi Dopazo, JJ; de Artaza Varasa, T; de la Cruz Perez, G; Gómez Moreno, AZ; Gómez Rodríguez, R; González de Frutos, C; Lanciego Pérez, C; Romero Gutiérrez, M | 1 |
| Bearz, A; Berretta, M; Cacopardo, B; Dal Maso, L; De Re, V; Di Benedetto, F; Facchini, G; Fiorica, F; Garlassi, E; Lleshi, A; Nasti, G; Spina, M; Tirelli, U | 1 |
1 review(s) available for sorafenib and HIV Infections
| Article | Year |
|---|---|
Hepatocellular carcinoma in patients with HIV.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Coinfection; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Liver Transplantation; Mass Screening; Niacinamide; Phenylurea Compounds; Sorafenib | 2017 |
1 trial(s) available for sorafenib and HIV Infections
| Article | Year |
|---|---|
Real-life experience with sorafenib for the treatment of hepatocellular carcinoma in HIV-infected patients.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Retrospective Studies; Sorafenib; Spain; Survival Analysis; Treatment Outcome | 2017 |
7 other study(ies) available for sorafenib and HIV Infections
| Article | Year |
|---|---|
Diffuse advanced hepatocellular carcinoma after HCV eradication in an HIV-infected patient: A unique complete response to sorafenib.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Coinfection; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Induction Chemotherapy; Liver Neoplasms; Male; Sorafenib | 2020 |
Unusual eruption in association with sorafenib: a case of acquired perforating dermatosis, reactive perforating collagenosis type.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Collagen Diseases; HIV Infections; Humans; Liver Neoplasms; Male; Skin Diseases; Sorafenib | 2018 |
Letter: Sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV-infected patients.
Topics: Adult; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; Chemical and Drug Induced Liver Injury; Drug Interactions; HIV Infections; Humans; Liver Neoplasms; Middle Aged; Niacinamide; Phenylurea Compounds; Protein Kinase Inhibitors; Sorafenib | 2013 |
Sorafenib therapy for hepatocellular carcinoma in an HIV-HCV coinfected patient: a case report.
Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Comorbidity; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Risk Factors; Sorafenib | 2010 |
Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report.
Topics: Aged; Antiretroviral Therapy, Highly Active; Benzenesulfonates; Carcinoma, Hepatocellular; Coinfection; Drug Synergism; Drug Therapy, Combination; Hepatitis B; HIV Infections; Humans; Liver Neoplasms; Male; Niacinamide; Phenylurea Compounds; Pyridines; Sorafenib; Treatment Outcome | 2011 |
[Clinical characteristics, staging and treatment of patients with hepatocellular carcinoma in clinical practice. Prospective study of 136 patients].
Topics: Aged; Alcoholism; Benzenesulfonates; Carcinoma, Hepatocellular; Comorbidity; Diabetes Mellitus; Early Detection of Cancer; Ethanol; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Neoplasms, Second Primary; Niacinamide; Phenylurea Compounds; Prospective Studies; Pyridines; Sclerotherapy; Sorafenib; Spain | 2011 |
Sorafenib for the treatment of unresectable hepatocellular carcinoma in HIV-positive patients.
Topics: Adult; Aged; Antineoplastic Agents; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; Disease Progression; Female; HIV Infections; Humans; Liver Neoplasms; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Retrospective Studies; Sorafenib; Treatment Outcome | 2013 |